Question

Difficulty: HardPharmacologic Interventions

A 64-year-old man is admitted to the general medical ward for a 3-day history of productive cough, high fevers, and right-sided pleuritic chest pain. His medical history is significant for coronary artery disease, hypertension, and highly symptomatic paroxysmal atrial fibrillation. His daily medications include dofetilide, apixaban, lisinopril, and atorvastatin. His temperature is 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), blood pressure is 118/76 mmHg118/76\text{ mmHg}, pulse is 78/min78/\text{min}, respiratory rate is 22/min22/\text{min}, and oxygen saturation is 92%92\% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. Laboratory studies show a leukocyte count of 14,500/μL14,500/\mu\text{L} with 82%82\% neutrophils. Serum electrolyte levels and renal function are within normal limits. An electrocardiogram demonstrates normal sinus rhythm with a corrected QT (QTc) interval of 475 ms475\text{ ms}. Chest radiography confirms a right lower lobe consolidation. Which of the following is the most appropriate empiric pharmacologic regimen for this patient?

  1. Ceftriaxone and doxycyclineAnswer
  2. B
    Ceftriaxone and azithromycin
  3. C
    Levofloxacin
  4. D
    Ciprofloxacin and doxycycline
  5. E
    Piperacillin-tazobactam and vancomycin

Answer

Ceftriaxone and doxycycline
The patient requires inpatient treatment for community-acquired pneumonia (CAP). Standard empiric therapy for non-ICU inpatients consists of a beta-lactam (e.g., ceftriaxone) combined with either a macrolide (e.g., azithromycin) or doxycycline, OR monotherapy with a respiratory fluoroquinolone (e.g., levofloxacin). However, this patient is taking dofetilide (a class III antiarrhythmic) and has a baseline QTc interval of 475 ms475\text{ ms} (upper limit of normal is typically 440−450 ms440-450\text{ ms}). Both macrolides and fluoroquinolones are known to prolong the QT interval and are associated with an increased risk of Torsades de Pointes. Coadministration of these agents with dofetilide is absolutely contraindicated. Doxycycline provides excellent coverage for atypical pneumonia pathogens and has no effect on the QT interval. Therefore, the combination of ceftriaxone and doxycycline is the safest and most appropriate pharmacologic intervention.

Step-by-Step Solution

1
Identify the primary clinical diagnosis and required level of care.
The patient has community-acquired pneumonia (CAP) requiring inpatient admission to the general medical ward.
Presence of fever, productive cough, focal lung findings, leukocytosis, and radiographic consolidation confirm CAP. Hypoxia (92%92\%) and comorbidities warrant inpatient care.
2
Determine the standard empiric antibiotic options for inpatient CAP (non-ICU).
Standard regimens include a beta-lactam plus a macrolide, a beta-lactam plus doxycycline, or a respiratory fluoroquinolone monotherapy.
Empiric therapy must cover both typical (S. pneumoniae, H. influenzae) and atypical (Mycoplasma, Legionella, Chlamydia) pathogens.
3
Analyze the patient's specific comorbidities and medication list for contraindications.
The patient is taking dofetilide (a class III antiarrhythmic) and has a prolonged baseline QTc of 475 ms475\text{ ms}.
Identifying drug-disease and drug-drug interactions is a critical step in pharmacologic management before initiating new antimicrobials.
4
Select the safest standard regimen that avoids exacerbating the identified risk.
Ceftriaxone and doxycycline is selected.
Macrolides (azithromycin) and fluoroquinolones (levofloxacin) block myocardial potassium channels and prolong the QTc interval. Doxycycline covers atypical pathogens without affecting the QTc.

Key Concept

Empiric inpatient CAP management in patients with prolonged QTc intervals
Estimated Time:1m 30s
Rate this question